Results 51 to 60 of about 19,743 (212)

Acute Neuromuscular Respiratory Weakness Due to Acute Inflammatory Demyelinating Polyneuropathy (AIDP): A Simulation Scenario for Neurology Providers. [PDF]

open access: yesMedEdPORTAL, 2019
Introduction Acute neuromuscular respiratory failure is a source of morbidity and mortality in neurological diseases, including acute inflammatory demyelinating polyneuropathy (AIDP), also known as Guillain-Barré syndrome. It is important for health care
Patel RA, Mohl L, Paetow G, Maiser S.
europepmc   +2 more sources

A comparison of IL-17 and IL-34 concentrations in the cerebrospinal fluid of patients with acute inflammatory demyelinating neuropathy and chronic inflammatory demyelinating polyneuropathy.

open access: yesRevista da Associação Médica Brasileira, 2020
OBJECTIVE The role of interleukins, such as IL-17 and IL-34, in the pathogenesis of autoimmune diseases has been established in the literature. In the current study, we aimed to identify the concentrations of IL-17 (IL-17A, IL-17F) and IL-34 in the ...
Hayriye Soytürk, M. Yılmaz
semanticscholar   +1 more source

Acute inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alfa-2a in a patient with chronic hepatitis C virus infection: a case report

open access: yesJournal of Medical Case Reports, 2012
Introduction The combination of polyethylene glycol (PEG)ylated interferon (pegylated interferon) and ribavirin has been shown to be an effective treatment for chronic hepatitis C virus. In general, common side effects related to this combination therapy
Lahbabi Mounia   +4 more
doaj   +1 more source

Characteristics of COVID and post COVID polyneuropathies in adults and pediatrics: an Egyptian sample

open access: yesThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021
Background The aim of this study is to describe the different forms of polyneuropathy associated with coronavirus disease 2019 (COVID-19) as a secondary neurological complication for (COVID-19) and the outcome from different therapeutic regimens in ...
Haidy Elshebawy   +2 more
doaj   +1 more source

Guillain-​Barré Syndrome Associated with COVID-19 Vaccination

open access: yesEmerging Infectious Diseases, 2021
We conducted a multi-institutional study in Taiwan and a systematic review of the literature for reports of Guillain-​Barré syndrome after coronavirus disease vaccination.
Shih-Chieh Shao   +5 more
doaj   +1 more source

Epidemiologic and Clinical Characteristics of Guillain-Barré Syndrome in Patients Referred to Sina Hospital in Hamadan in 2018 [PDF]

open access: yesInternational Journal of Epidemiologic Research, 2022
Background and aims: Guillain-Barré syndrome (GBS) has several types, some of which damage myelin and some others cause axonal damage. Detecting the type of GBS is important in determining the type of treatment and its prognosis. This study was conducted
Mojtaba Khazaei   +4 more
doaj   +1 more source

Case Report on Guillain Barre Syndrome: Acute Inflammatory Demyelinating Polyneuropathy

open access: yesInternational journal of research and review, 2021
Guillain Barre Syndrome (GBS) is an autoimmune disorder which affects the peripheral nervous system. It is a rare disorder affects in 1 per million people in year. It is characterized by symmetrical, progressive limb weakness and tingling. Case Report: A
C. Roy, J. Vilapurathu, Dhanya Paul
semanticscholar   +1 more source

Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy: a case report

open access: yesJournal of Medical Case Reports, 2008
Introduction Acute Human Immunodeficiency Virus infection is associated with a range of neurological conditions. Guillain-Barré syndrome is a rare presentation; acute inflammatory demyelinating polyneuropathy is the commonest form of Guillain-Barré ...
Sloan Derek J   +4 more
doaj   +1 more source

POEMS neuropathy: optimising diagnosis and management [PDF]

open access: yes, 2018
POEMS syndrome is a rare and disabling autoinflammatory condition characterised by a typical peripheral neuropathy and the presence of a monoclonal plasma cell disorder.
Carr, AS   +5 more
core   +1 more source

A Severe Course of Relapsing-Remitting Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy in a Young Man

open access: yesCase Reports in Neurology, 2021
Acute-onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) is an immune mediated neuropathy characterized by progressive weakness and sensory impairment lasting over 2 months.
A. Patnaik   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy